RE: Takeda30 Jun 2020 23:32
I have said this before, I have been ridiculed for this before, I will say it again. £1.80 per share.
@Toine there are several reasons why everyone has not bought hemo:
1, Hemogenyx has a small MCap, this makes it "invisible" to many investors, funds, research groups and investment companies, they will have a minimum MCap and below that they plain and simple will not look at a company, I know one such limit is £50m.
2, Hemogenyx right now has not made a profit, they have sold some mice but they are keeping details on customers, figures, royalty payments etc VERY hush hush, We know Orgenesis have released the BioDefence Platform using Hemo mice and from that we get 12% royalties, but we dont yet know how much Orgenesis expect to make PA.
3, Hemogenyx have not started human trials (That we know about), because of the mice we PIs on this board know the trials will be fine, but until they work they dont work. One or more trials MAY fail, its possible, we have been told that early results are very promissing and should pass but thats buried in multiple RNS's a casual first time visitor investor wont bother reading that.
4, Probably the biggie - ALOT of people read the 3 month extension to the Global Co agreement as a 3 month delay. In reality it is nothing of the sort, its a 3 month extension to do more work because the scope of the agreement has expanded. Its also a 3 month window, Vlad is not a moron, he would have allowed probably a month of buffer space to allow for further delays, so probably due in the next 3 weeks. Problem for some investors is they THOUGHT they had 2.9 months to go and invest and play the market elsewhere, then return in time for Global Co. It does not work like that, but it explains why they have not invested.
All that aside people are loading up, I see many many 250k, 500k, 1mil share purchases, people with that sort of money are not playing games.